Crossmark

Tapering of biological antirheumatic drugs in rheumatoid arthritis patients is achievable and cost-effective in daily clinical practice: data from the Brussels UCLouvain RA Cohort

Crossref DOI link: https://doi.org/10.1186/s13075-020-02165-4

Published Online: 2020-04-28

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dierckx, Stéphanie

Sokolova, Tatiana

Lauwerys, Bernard R.

Avramovska, Aleksandra

de Bellefon, Laurent Meric

Toukap, Adrien Nzeusseu

Stoenoiu, Maria

Houssiau, Frédéric A.

Durez, Patrick
License Information

Text and Data Mining valid from 2020-04-28

Version of Record valid from 2020-04-28
More Information

Article History

Received: 17 October 2019

Accepted: 27 March 2020

First Online: 28 April 2020

Ethics approval and consent to participate

: This retrospective non-interventional study was retrospectively registered with local ethics approval. No additional consent form needed for this retrospective non-interventional SOC study.

: An institutional consent form was used for publication.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below